The Pennsylvania Superior Court's recent decision not to apply blanket pre-emption to failure-to-warn claims against the makers of the generic version of acid reflux drug Reglan ignores U.S. Supreme Court precedent and makes Pennsylvania an outlier among the other states that have ruled on similar issues, some attorneys said.
PA Court Ignored SCOTUS in Reglan Ruling
The PA Superior Court's recent decision not to apply blanket pre-emption to failure-to-warn claims against the makers of the generic version of drug Reglan ignores U.S. Supreme Court precedent ...
This premium content is locked for LawJournalNewsletters subscribers only
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN LawJournalNewsletters
- Stay current on the latest information, rulings, regulations, and trends
- Includes practical, must-have information on copyrights, royalties, AI, and more
- Tap into expert guidance from top entertainment lawyers and experts
Already have an account? Sign In Now
For enterprise-wide or corporate access, please contact Customer Service at [email protected] or call 1-877-256-2473.






